The Supreme Court decided Thursday to allow women to have access to the abortion pill mifepristone through telehealth visits as the issue makes it way through lower courts.

The high court previously placed a pause on an appeals court decision that would block access to the abortion drug amid an ongoing lawsuit, which was set to expire Thursday. 

Conservative Supreme Court Justices Samuel Alito and Clarence Thomas dissented from the order, which granted emergency requests brought by drugmakers Danco Laboratories and GenBioPro seeking to block the appeals court ruling, per NBC News.

The case involves mifepristone, one of the two drugs used in abortions, and a federal rule from the Food and Drug Administration allowing telehealth prescription of the drug, and its delivery through the mail.

Louisiana law requires that a woman make an in-person visit to a healthcare provider to receive the prescription. But the state also has an abortion ban that significantly limits the circumstances in which a woman can have an abortion.

The Fifth Circuit ruling saw the court opine that Louisiana was likely to succeed on the merits of the case.

Misty Severi is a news reporter for Just The News. You can follow her on X for more coverage.